101 related articles for article (PubMed ID: 2334175)
1. [Side effects of high dose methotrexate with citrovorum factor therapy: relationship between clinical data and serum concentration of methotrexate].
Watanabe M; Yanagisawa M; Sato K
Gan To Kagaku Ryoho; 1990 May; 17(5):1081-4. PubMed ID: 2334175
[No Abstract] [Full Text] [Related]
2. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
[No Abstract] [Full Text] [Related]
3. [Management of the administration of leucovorin calcium in high-dose methotrexate therapy].
Kickinger W; Ritschl P; Kotz R
Arzneimittelforschung; 1989 Jun; 39(6):728-31. PubMed ID: 2789050
[TBL] [Abstract][Full Text] [Related]
4. [Bolus and maintenance infusion of high-dose methotrexate].
Amino K; Kawaguchi N; Matsumoto S; Manabe J; Tabata D; Machida M
Gan To Kagaku Ryoho; 1989 May; 16(5):2045-9. PubMed ID: 2730094
[TBL] [Abstract][Full Text] [Related]
5. High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.
Nirenberg A; Mosende C; Mehta BM; Gisolfi AL; Rosen G
Cancer Treat Rep; 1977 Aug; 61(5):779-83. PubMed ID: 302143
[No Abstract] [Full Text] [Related]
6. [The influence of liver and renal functions on the changes in serum methotrexate (MTX) level in high-dose MTX therapy].
Sato T; Nakanishi K; Takahashi M; Sato K; Miura T; Kuzuya T; Mizuno M
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2375-9. PubMed ID: 2260874
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of high-dose methotrexate with modified citrovorum factor rescue.
Jacobs SA; Santicky MJ
Cancer Treat Rep; 1978 Mar; 62(3):397-9. PubMed ID: 348306
[No Abstract] [Full Text] [Related]
8. Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue.
Allen JC; Rosen G; Mehta BM; Horten B
Cancer Treat Rep; 1980; 64(12):1261-73. PubMed ID: 6970616
[TBL] [Abstract][Full Text] [Related]
9. Effect of high-dose methotrexate with citrovorum factor on human granulopoiesis.
Schremi W; Lohrmann HP
Cancer Res; 1979 Oct; 39(10):4195-9. PubMed ID: 314330
[TBL] [Abstract][Full Text] [Related]
10. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
Jaffe N
Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
[No Abstract] [Full Text] [Related]
11. Dose escalation with pharmacokinetics monitoring in methotrexate chemotherapy of osteosarcoma.
Delepine N; Delepine G; Cornille H; Brion F; Arnaud P; Desbois JC
Anticancer Res; 1995; 15(2):489-94. PubMed ID: 7763028
[TBL] [Abstract][Full Text] [Related]
12. [The results of using high-dose methotrexate in treating osteogenic sarcoma].
Perevodchikova NI; Eremina LA; Manziuk LV; Siniukov PA; Fedenko AN; Singin AS; Moldovanova LK
Vopr Onkol; 1990; 36(6):667-71. PubMed ID: 2378085
[TBL] [Abstract][Full Text] [Related]
13. High dose methotrexate therapy of solid tumors: observations relating to clinical toxicity.
Isacoff WH; Townsend CM; Eiber FR; Forster T; Morton DL; Block JB
Med Pediatr Oncol; 1976; 2(3):319-25. PubMed ID: 1086423
[TBL] [Abstract][Full Text] [Related]
14. [High-dose methotrexate with citrovorum factor rescue in the treatment of malignant tumors (author's transl)].
Wang QL; Sun Y; Zhou JC; Song SZ; Lu L; Ye ZS
Zhonghua Zhong Liu Za Zhi; 1979; 1(2):144-9. PubMed ID: 317948
[No Abstract] [Full Text] [Related]
15. Antineoplastic agents: high-dose methotrexate and citrovorum factor rescue.
Sadée W
Ther Drug Monit; 1980; 2(2):177-85. PubMed ID: 6762711
[TBL] [Abstract][Full Text] [Related]
16. [Radiational basis and practice of the citrovorum factor (Leucovorin) protection after high-dose methotrexate therapy. High-dose methotrexate/leucovorin].
Sauer H; Schalhorn A
Onkologie; 1980 Apr; 3(2):64-71. PubMed ID: 6994007
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy of advanced bone and soft tissue sarcoma].
Yamawaki S; Isu K; Ubayama Y; Yamaguti H; Gotou M
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1757-63. PubMed ID: 6541020
[TBL] [Abstract][Full Text] [Related]
18. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.
Jaffe N; Paed D; Farber S; Traggis D; Geiser C; Kim BS; Das L; Frauenberger G; Djerassi I; Cassady JR
Cancer; 1973 Jun; 31(6):1367-73. PubMed ID: 4541163
[No Abstract] [Full Text] [Related]
19. [Moderate dose methotrexate with citrovorum factor rescue therapy in the treatment of head and neck cancer].
Inuyama Y; Hiroto I; Taketa C; Horiuchi M; Mashino S; Fujii M; Matsuura S; Satake B; Takeoda S; Nishijima W; Okuda M; Sakaguchi K; Tanigaito Y; Imakirei M; Konno T; Hirokawa T; Takada K; Ono I; Saitoh H; Takemiya S; Shimada F; Omura K; Miyake H; Fujii K; Kawabe Y; Kondoh T; Komiyama S; Yanagida T; Matsumura Y; Hirano M; Araki S
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2193-200. PubMed ID: 6764099
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of severe side effects of high-dose methotrexate in osteosarcoma].
Umeda T; Takada N; Hodaka E; Endoh F; Ishii T
Gan To Kagaku Ryoho; 1984 Feb; 11(2):285-94. PubMed ID: 6582805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
